My PCR
Create Account
Logo PCR

PCR Valves e-Course: Hot Lines and Late-Breaking Trials

Get an overview of the Hot Lines and Late-breaking Trials that will be released during #PCRValves

PCR Valves e-Course 2020 will feature an exciting number of Hot Lines covering the full range of what is new in the field of Valvular Interventions, and presented by renowned cardiac valve specialists from around the world.

Main arena

Hotline session 1

  • The percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION: the ACTIVATION trial - Simon Redwood
  • Prospective, single-arm clinical investigation for the safety and feasibility study of Valvosoft Non-Invasive Ultrasound Therapy (NIUT) in patients with severe symptomatic calcific aortic stenosis - First-in-man - Emmanuel Messas
  • Outcomes of mitral valve surgery after transcatheter edge-to-edge mitral valve repair: the CUTTING-EDGE registry - Gilbert Tang

Hotline session II

  • Contemporary, real-world, clinical outcomes with the next generation MitraClip (NTR/XTR) system in patients with secondary MR: results from the global EXPAND study - Jorg Hausleiter
  • Transcatheter mitral edge-to-edge repair with the DragonFly valve repair device - Early feasibility study - Jian-An Wang
  • Two-year outcomes of mitral valve-in-MAC, valve-in-ring and valve-in-valve in the MITRAL trial - Mayra Guerrero

Hotline session III

  • Analysis of costs and quality of life at one year in the UK TAVI trial - Ines Rombach
  • Long-term follow-up of transcatheter and surgical bioprosthetic aortic valves in patients with severe aortic stenosis and lower surgical risk - Lars Sondergaard
  • A clinical evaluation of the HYDRA self-expanding transcatheter aortic valve: 30-day and one-year results from the Hydra CE study - Lars Sondergaard

Cases and Abstracts Corner

Hotline session IV

  • Contemporary clinical outcomes with TMVR using the MitraClip G4 system: core laboratory echocardiographic results in the EXPAND G4 study - Bassem M. Chehab
  • Off-label use of transaxillary TAVI with a self-expandable device - Ignacio J. Amat-Santos
  • Safety and efficacy of next-generation balloon-expandable THV: twelve-month outcomes of the MyVal-1 study - Ravinder Rao
  • Surgical EXPLANTation After TAVR Failure: subgroup analyses from the EXPLANT-TAVR international registry - Paolo Denti